Laser treatment for chronic central serous chorioretinopathy
Part of Eyes & vision clinical trials.
This study tests a gentle laser treatment called micropulse laser for people with chronic central serous chorioretinopathy. It aims to help dry up the fluid under the retina that has not responded to standard medications for at least 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with central serous chorioretinopathy (fluid buildup under the retina) that did not improve after 6 months of treatment with two specific medications (Acetazolamide and Eplerenone).
- The fluid under the center of your retina has been present for at least 6 months.
- You are 18 years or older and can read and understand the informed consent form.
- You have not had any other retinal treatments for this condition besides the two medications mentioned.
- You do not have other eye diseases such as age-related macular degeneration, diabetic retinopathy, or abnormal blood vessels in the eye.
- You do not have severe nearsightedness or farsightedness (more than 6 diopters) or uncontrolled glaucoma requiring eyedrops.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the link between gut bacteria and central serous chorioretinopathy (CSC), a condition where fluid builds up under the retina. It may help us understand why some people get CSC and find better ways to treat it.
This trial tests whether taking oral melatonin can help people with acute central serous chorioretinopathy, a condition where fluid builds up under the retina and causes blurred vision. If effective, this simple treatment might help improve vision and speed up recovery.
This study tests whether mindfulness practices can help people with central serous chorioretinopathy, a condition where fluid builds up under the retina and blurs vision. It aims to see if mindfulness reduces stress and improves recovery compared to usual care.
This trial studies a mild (“subthreshold”) laser treatment for reticular pseudodrusen (RPD) caused by age-related macular degeneration (AMD). If you qualify, the goal is to see whether the laser helps preserve or improve vision by targeting these specific eye changes.
This study tests whether a micropulsed laser can reduce swelling in the macula (central vision area) in people with inherited retinal diseases. It may help improve or stabilize vision-related swelling seen on detailed eye scans.
This trial tests a special laser treatment for diabetic macular edema, a swelling in the back of the eye caused by diabetes. It aims to see if the laser can help patients who have not improved with standard treatment.
Hear when a new Central Serous Chorioretinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.